Treatment of Nasal Cellulitis Caused by Coagulase-Negative Staphylococci
For nasal cellulitis caused by coagulase-negative staphylococci (CoNS), the recommended first-line treatment is clindamycin 300-450 mg orally three times daily or 600 mg IV three times daily for 5-6 days.
Antibiotic Selection
First-line options:
- Clindamycin: 300-450 mg orally three times daily or 600 mg IV three times daily 1
- Provides excellent coverage for both CoNS and potential beta-hemolytic streptococci
- Achieves adequate levels in nasal secretions to eliminate staphylococci 2
Alternative options (if clindamycin cannot be used):
- Linezolid: 600 mg orally/IV twice daily 2, 1
- Vancomycin: 15-20 mg/kg IV every 8-12 hours (for severe infections) 1, 3
- Trimethoprim-sulfamethoxazole (TMP-SMX) plus a beta-lactam 1
Duration of Therapy
- 5-6 days is sufficient for uncomplicated nasal cellulitis 2
- Consider extending treatment if infection has not improved after 5 days 2
- For severe or complicated infections, treatment may need to be extended to 7-14 days 2
Additional Management
- Incision and drainage if there is a purulent collection or abscess formation 2, 1
- Elevation of the affected area to promote drainage of edema and inflammatory substances 1
- Wound care:
- Keep draining wounds covered with clean, dry bandages
- Maintain good personal hygiene with regular handwashing 2
Special Considerations
Antibiotic Resistance
- CoNS strains have shown high resistance to penicillin, oxacillin, and erythromycin 4
- Medium resistance to tetracycline, ciprofloxacin, and trimethoprim/sulfamethoxazole 4
- Low resistance to rifampicin, ceftizoxime, and gentamicin 4
- 100% sensitivity has been reported to vancomycin and cefotaxime 5
For Recurrent Infections
- Identify and treat predisposing conditions 2
- Consider decolonization strategies:
- For patients with 3-4 episodes per year, consider prophylactic antibiotics:
Monitoring and Follow-up
- Monitor for improvement within 48-72 hours of initiating treatment
- Watch for signs of treatment failure:
- Increasing erythema, edema, or pain
- Development of systemic symptoms (fever, tachycardia)
- For clindamycin therapy, monitor for diarrhea and potential C. difficile infection 1
Pitfalls and Caveats
- Don't overlook nasal examination: Occult nasal infections can be the source of aggressive ascending facial and orbital cellulitis 6
- Don't underdose antibiotics: Inadequate dosing is associated with clinical failure 1
- Don't miss MRSA: While CoNS is the focus, consider MRSA coverage if risk factors are present (prior MRSA infection, recent hospitalization, recent antibiotics) 7
- Don't forget to culture: Obtain cultures before starting antibiotics to guide therapy, especially in severe or non-responsive cases 2
By following these guidelines, most cases of nasal cellulitis caused by coagulase-negative staphylococci can be effectively managed with a short course of appropriate antibiotics, with clindamycin being the preferred first-line agent.